以奥密克戎BA.5和BA.2亚变异株为主的2022-2023季节新冠加强针接种在医务人员中的有效性、发病与缺勤情况
研究随访希腊5752名医务人员(2022年11月14日至2023年5月28日),评估新冠加强针接种有效性及发病与缺勤关联。完全接种(基础免疫加6个月内一剂加强针)对新冠调整有效性为62.8%(95%CI 18.6%-83.0%),且与更短缺勤时间相关(aOR 0.42;95%CI 0.21-0.83)。
要点
- 完全接种者新冠调整有效性为62.8%(95%CI 18.6%-83.0%)。
- 完全接种者缺勤时间更短(aOR 0.42;95%CI 0.21-0.83)。
- 完全接种者发生无症状SARS-CoV-2感染的可能性更高(aOR 5.90;95%CI 1.27-27.45)。
核心结论
- 新冠仍是医务人员发病和缺勤的重要原因,完全接种状态对新冠提供显著保护并与更短缺勤时间相关。
研究设计与样本
- 前瞻性随访希腊5752名医务人员,随访期2022年11月14日至2023年5月28日,观察缺勤事件。
主要发现
- 研究期间共发生1029次缺勤事件(每100名医务人员17.9次),每次缺勤平均5.2天,总缺勤5237天。
- 新冠确诊736人(12.8%),无症状SARS-CoV-2感染62人(1.1%),流感95人(1.7%)。
- 新冠、流感和无症状SARS-CoV-2感染分别占缺勤事件的71.5%、9.2%和6.0%。
- 完全接种者缺勤时间更短(aOR 0.42;95%CI 0.21-0.83),发生新冠可能性更低(aOR 0.37;95%CI 0.17-0.81),发生无症状SARS-CoV-2感染可能性更高(aOR 5.90;95%CI 1.27-27.45)。
- 完全接种对新冠的调整有效性为62.8%(95%CI 18.6%-83.0%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: We assessed the vaccination effectiveness (VE) of a COVID-19 booster vaccine dose and the association between morbidity and absenteeism with COVID-19 booster vaccine receipt among healthcare personnel (HCP) in 2022-2023 in Greece. METHODS: We followed 5752 HCP from November 14, 2022 through May 28, 2023 for episodes of absenteeism. Absenteeism for non-infectious causes, pregnancy leave, or annual leave was not recorded. Full vaccination was defined as a primary vaccination series plus one booster dose within the past six months. Multivariable regression models were used to estimate the association of full COVID-19 vaccination with the outcomes of interest. RESULTS: A total of 1029 episodes of absenteeism occurred during the study period (17.9 episodes per 100 HCP). The mean duration of absence per episode was 5.2 days, and the total duration of absence was 5237 days. COVID-19 was diagnosed in 736 (12.8 %) HCP, asymptomatic SARS-CoV-2 infection in 62 (1.1 %) HCP, and influenza in 95 (1.7 %) HCP. Overall, COVID-19, influenza, and asymptomatic SARS-CoV-2 infection accounted for 71.5 %, 9.2 %, and 6.0 % of episodes of absenteeism, respectively. Multivariable regression models indicated that fully vaccinated HCP were absent from work for shorter periods [adjusted odds ratio (aOR): 0.42; 95 % confidence interval (CI): 0.21-0.83], were less likely to develop COVID-19 [aOR: 0.37; 95 % CI: 0.17-0.81)], and were more likely to develop an asymptomatic SARS-CoV-2 infection (aOR: 5.90; 95 % CI: 1.27-27.45). The adjusted full VE against COVID-19 was 62.8 % (95 % CI: 18.6 %-83.0 %). CONCLUSIONS: COVID-19 remains a significant cause of morbidity and absenteeism among HCP. Full COVID-19 vaccination status conferred significant protection against COVID-19 and was associated with shorter periods of absence from work.
引用
- Maltezou HC, Gamaletsou MN, Giannouchos TV, et al. Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants. Vaccine. 2024. PMID: 38729911. doi:10.1016/j.vaccine.2024.04.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。